Robbins Arroyo LLP Is Investigating the Officers and Directors of Pulse Biosciences, Inc. (PLSE) on Behalf of
Shareholders
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Pulse Biosciences, Inc. (NasdaqCM: PLSE) breached their
fiduciary duties to shareholders. Pulse Biosciences, a clinical-stage medical technology company, develops therapeutic tissue
treatment platform based on its proprietary nano-pulse stimulation technology.
View this information on the law firm's Shareholder Rights Blog: www.robbinsarroyo.com/pulse-biosciences-inc
Pulse Biosciences Shareholders Have Legal Options
If you would like more information about your rights and potential remedies, contact attorney Leonid Kandinov at (800) 350-6003,
LKandinov@robbinsarroyo.com, or via the shareholder information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional
investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion
of value for themselves and the companies in which they have invested.
Attorney Advertising. Past results do not guarantee a similar outcome.
Robbins Arroyo LLP
Leonid Kandinov
(619) 525-3990 or Toll Free (800) 350-6003
LKandinov@robbinsarroyo.com
www.robbinsarroyo.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180625006325/en/